|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/351 |
| (11) | Number of the document | 3057585 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14853953.9 |
| Date of filing the European patent application | 2014-10-14 | |
| (97) | Date of publication of the European application | 2016-08-24 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2014/060477 |
| Date | 2014-10-14 |
| (87) | Number | WO 2015/057699 |
| Date | 2015-04-23 |
| (30) | Number | Date | Country code |
| 201361891320 P | 2013-10-15 | US | |
| 201461941904 P | 2014-02-19 | US | |
| 201461947742 P | 2014-03-04 | US | |
| 201461975318 P | 2014-04-04 | US |
| (72) |
LYON, Robert, US
BURKE, Patrick, US
HUNTER, Joshua, US
|
| (73) |
Seagen Inc.,
21823 30th Drive, S.E., Bothell, WA 98021,
US
|
| (54) | PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS |
| PEGYLATED DRUG-LINKERS FOR IMPROVED LIGAND-DRUG CONJUGATE PHARMACOKINETICS |